MADISON, Wis. — If you are looking to shake up your career, Exact Sciences has just the opportunity for you. The biotech company, known for...
6 hours ago

MADISON, Wis., May 01, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests,...
5 days ago

Exact Sciences posts positive data for its capsule-on-a-string test for esophageal cancer ... Exact Sciences has put forward positive data on its...
1 month ago

MADISON, Wis., Jan. 7, 2024 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests,...
3 months ago

Exact Sciences issued a news release earlier this afternoon detailing our fourth quarter financial results. This news release and today's...
2 months ago

Cathie Wood Darling Exact Sciences, And Rival Guardant Health, Dip On Colon Cancer Updates ... Shares of Guardant Health (GH) and Exact Sciences (...
1 month ago

Exact Sciences' (NDAQ: EXAS) history is a tale of two halves. Founded in 1995 in Marlborough, Massachusetts, “Exact,” as the company is...
1 month ago

MADISON, Wis., April 15, 2024--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today...
3 weeks ago

Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.
1 month ago

PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the...
6 months ago